Loading
TAMPA — Accentia Biopharmaceuticals Chief Financial Officer Alan Pearce resigned from his position with the company at the end of 2010, a filing with the Securities & Exchange Commission shows.
Pearce will remain with the company as a director until its next annual shareholder meeting, scheduled for Jan. 19.
Along with its subsidiary Biovest International Inc., Accentia emerged from Chapter 11 bankruptcy in November of last year. With $10.46 million in revenues, the company lost $47.8 million in the twelve months ended Sept. 30, 2010.
Your free article limit has been reached this month.
Subscribe now for unlimited digital access to our award-winning business news.
Join thousands of executives who rely on us for insights spanning Tampa Bay to Naples.
